It has been shown that high levels of PD-1 (PDCD1) expression correlate with increased numbers of tumor-infiltrating Tregs and decreased numbers of effector T cells in the TME of CRC, which can be reversed by immune checkpoint blockades (ICB) (44, 45). This evidence concerns the gene PDCD1 and colorectal carcinoma.